Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E-/- mice in vivo. [electronic resource]
Producer: 20030523Description: 2480-6 p. digitalISSN:- 1524-4539
- Animals
- Aorta -- drug effects
- Apolipoproteins E -- deficiency
- Autonomic Nervous System -- physiopathology
- Blood Pressure -- drug effects
- Blood Pressure Monitoring, Ambulatory
- Caveolin 1
- Caveolins -- metabolism
- Cholesterol -- blood
- Chronobiology Disorders -- complications
- Electrocardiography, Ambulatory
- Fluorobenzenes -- pharmacology
- Heart Rate -- drug effects
- Hyperlipidemias -- complications
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- Myocardium -- metabolism
- Nitric Oxide -- metabolism
- Nitric Oxide Synthase -- metabolism
- Nitric Oxide Synthase Type II
- Nitric Oxide Synthase Type III
- Pyrimidines
- Rosuvastatin Calcium
- Sulfonamides
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.